Taiho Oncology, Inc.
Julie Baron, Ph.D. has extensive experience in the medical affairs field, with a strong focus on oncology. Julie has held various leadership roles in companies such as Taiho Oncology, Exact Sciences, Shire, and Amgen. With a background in molecular biology and research work in neuro-oncology, Julie has a deep understanding of the medical field. Throughout their career, Julie has demonstrated a commitment to developing and implementing medical strategies for product launches, as well as overseeing medical teams and activities in various regions. Julie's expertise lies in areas such as pharmacovigilance, regulatory affairs, and medical communication, making their a valuable asset in the medical affairs industry.
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com